On the basis of these results, it could be assumed that estrogenic GPER signalling couples the expression of both IL1β in CAFs and IL1R1 in breast cancer cells, thus generating a feedforward IL1beta/IL1R1 response. The gene discussed is IL1B; the disease is breast cancer.